NR1I2 and metabolic dysfunction-associated steatotic liver disease: MASLD is a nonalcoholic steatotic liver disease [74], and its pathogenesis may be closely related with PXR signaling as exemplified by PXR target Cyp3a11 being upregulated during MASLD progression in mice [75].